Search results
Is Novartis AG (NYSE:NVS) Investors’ Favorite International Dividend Stock?
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since Novartis AG...
Capital Research Global Investors Increases Stock Position in Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 7 days agoCapital Research Global Investors raised its position in shares of Novartis AG (NYSE:NVS – Free Report) by 0.0% in the 4th quarter, according to its most recent 13F filing ...
Radioactive drugs strike cancer with precision
Knowable Magazine via Yahoo News· 1 day agoThe move follows similar billion-dollar-plus transactions made in recent months by Bristol Myers Squibb (BMS) and Eli Lilly, along with earlier takeovers...
NHS and ABPI announce new guidelines ahead of UK elections
Pharmaceutical Technology via Yahoo Finance· 8 hours agoSpeaking on a panel discussing the guidelines, Pauline Hakutangwi, value and access marketing...
Voyager Therapeutics appoints new CFO By Investing.com
Investing.com· 13 hours agoVoyager Therapeutics (NASDAQ:VYGR), Inc., a biotechnology firm specializing in the development of...
Tirzepatide Shows Improvements in MASH Resolution, Fibrosis
Medscape· 4 days agoEncouraging phase 2 results of tirzepatide in the resolution of MASH and improvement in fibrosis...
Fumihiko Maki, honored architect of understated buildings, dies at 95 - The Boston Globe
The Boston Globe· 1 day agoIn an interview for this obituary in 2010, Mr. Maki said his goal was not to make his buildings...
Why Alcon (ALC) is a Top Momentum Stock for the Long-Term
Zacks via Yahoo Finance· 4 days agoFrom Mar 20, 2002 until its 2011-merger into Novartis, Alcon was publicly listed and traded on the...
Ongoing Efforts to Expand Kidney Donor Pool Seem Mostly Safe
Medscape· 2 days agoLiving donors had a similar risk for hypertension and albuminuria after donation as nondonors, and...
A Benefit to Add-On Abemaciclib in Advanced Breast Cancer?
Medscape· 21 hours agoAdding abemaciclib to an aromatase inhibitor improved overall survival in HR+/HER2− advanced breast...